Shares of Oppenheimer Holdings, Inc. (NYSE:OPY – Get Free Report) saw unusually-high trading volume on Friday after the company announced a dividend. Approximately 59,955 shares traded hands during mid-day trading, an increase of 5% from the previous session’s volume of 57,332 shares.The stock last traded at $111.80 and had previously closed at $114.48.
The newly announced dividend which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.8%. This is a boost from Oppenheimer’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Friday, May 15th. Oppenheimer’s payout ratio is presently 8.58%.
Wall Street Analyst Weigh In
OPY has been the subject of a number of analyst reports. Cantor Fitzgerald downgraded Oppenheimer to a “buy” rating in a research note on Wednesday, January 7th. Wall Street Zen raised Oppenheimer from a “buy” rating to a “strong-buy” rating in a research note on Saturday, March 7th. Finally, Weiss Ratings raised Oppenheimer from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, April 21st. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Oppenheimer currently has a consensus rating of “Buy”.
Oppenheimer Price Performance
The stock has a market cap of $1.14 billion, a P/E ratio of 12.66 and a beta of 1.19. The stock has a 50-day simple moving average of $95.11 and a 200-day simple moving average of $81.45.
Oppenheimer (NYSE:OPY – Get Free Report) last issued its earnings results on Friday, May 1st. The financial services provider reported $4.21 EPS for the quarter. The firm had revenue of $445.10 million during the quarter. Oppenheimer had a return on equity of 16.10% and a net margin of 9.06%.
Key Stories Impacting Oppenheimer
Here are the key news stories impacting Oppenheimer this week:
- Positive Sentiment: Revenue growth: Oppenheimer reported quarterly revenue of $445.1M (up ~21% YoY), showing continued top-line strength that supports long‑term business demand. Oppenheimer Holdings Inc. Reports First Quarter 2026 Earnings
- Positive Sentiment: Institutional buying: Several large funds increased positions in Q4 2025 (e.g., Millennium, State Street), indicating some investor confidence at institutional levels. Oppenheimer Holdings Inc. (OPY) Stock Falls on Q1 2026 Earnings
- Neutral Sentiment: Analyst & research activity largely concerns Oppenheimer’s coverage of other stocks (e.g., coverage on small‑caps and tech names) rather than changes to Oppenheimer’s own guidance — limited direct impact on OPY fundamentals. Why Climb Bio (CLYM) is One of the Best Performing Small Cap Stocks So Far in 2026
- Negative Sentiment: Profitability shock: The company reported a net loss of $20.6M (‑$1.93/share) in Q1 2026 versus net income in the year‑ago quarter, and an operating loss — a clear earnings miss that pressured the stock. Oppenheimer Holdings Inc. Reports First Quarter 2026 Earnings
- Negative Sentiment: Cash burn & balance sheet items: Q1 cash used in operations was large (reported ~‑$190M), capex jumped (~$60M), cash on hand fell to roughly $34.6M and total liabilities rose — raising short‑term liquidity and execution concerns. Oppenheimer Holdings Inc. (OPY) Stock Falls on Q1 2026 Earnings
- Negative Sentiment: Insider sale & short interest: A small insider sale was reported and short interest has risen materially, both of which can amplify downward pressure on the stock in the near term. Oppenheimer Holdings Inc. (OPY) Stock Falls on Q1 2026 Earnings Oppenheimer Holdings, Inc. (NYSE:OPY) Sees Large Increase in Short Interest
Insider Buying and Selling
In other Oppenheimer news, insider Dennis P. Mcnamara sold 4,673 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $90.67, for a total transaction of $423,700.91. Following the completion of the transaction, the insider owned 20,177 shares of the company’s stock, valued at approximately $1,829,448.59. The trade was a 18.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 34.86% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. State of Alaska Department of Revenue acquired a new position in Oppenheimer during the third quarter worth about $31,000. Arax Advisory Partners raised its stake in Oppenheimer by 47,700.0% during the fourth quarter. Arax Advisory Partners now owns 478 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 477 shares in the last quarter. Torren Management LLC acquired a new position in Oppenheimer during the fourth quarter worth about $38,000. Barclays PLC acquired a new position in Oppenheimer during the fourth quarter worth about $40,000. Finally, Clearstead Advisors LLC grew its holdings in shares of Oppenheimer by 193.9% during the fourth quarter. Clearstead Advisors LLC now owns 629 shares of the financial services provider’s stock worth $45,000 after purchasing an additional 415 shares during the last quarter. Institutional investors and hedge funds own 32.26% of the company’s stock.
About Oppenheimer
Oppenheimer & Co Inc is a full-service investment bank and wealth management firm headquartered in New York City. Founded in the mid-20th century, the company provides a broad array of financial services to individual, institutional and corporate clients. Its core competencies include equity and fixed-income research, institutional sales and trading, underwriting and merger-and-acquisition advisory.
In the wealth management segment, Oppenheimer offers tailored investment solutions, comprehensive financial planning and retirement strategies.
Featured Articles
Receive News & Ratings for Oppenheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oppenheimer and related companies with MarketBeat.com's FREE daily email newsletter.
